Demo Sign up Log In

AgeX Therapeutics, Inc. (AGE)

EV to Operating Cash Flow

-0.23×

TTM · Retrieved: Oct 25, 2026

AGE EV to Operating Cash Flow

Current (TTM)-0.23×retrievedOct 25, 2026

Current (TTM)-0.23×retrievedOct 25, 2026

AGE Quarterly EV/OCF (0.00× → -1.79×)

Latest values, visible window

High-resolution chart · PNG

AGE ev to operating cash flow history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. EV to Operating Cash Flow — Quarterly
Period ending	EV to Operating Cash Flow
Jun 30, 2026	-1.7911×
Mar 31, 2026	-0.4409×
Dec 31, 2025	-3.2403×
Sep 30, 2025	-12.986×
Jun 30, 2025	-14.8716×
Mar 31, 2025	-11.8641×
Dec 31, 2024	-8.9212×
Sep 30, 2024	-22.787×
Jun 30, 2024	-9.9587×
Mar 31, 2024	-22.5832×
Dec 31, 2023	90.1839×
Sep 30, 2023	-53.7276×
Jun 30, 2023	-77.7334×
Mar 31, 2023	-78.0321×
Dec 31, 2022	-29.3312×
Sep 30, 2022	-29.8011×
Jun 30, 2022	-20.1683×
Mar 31, 2022	-26.4798×
Dec 31, 2021	-33.1601×
Sep 30, 2021	-24.8875×
Jun 30, 2021	-40.2732×
Mar 31, 2021	-26.0893×
Dec 31, 2020	-39.4756×
Sep 30, 2020	-18.7453×
Jun 30, 2020	-17.5506×
Mar 31, 2020	-18.012×
Dec 31, 2019	-28.6958×
Sep 30, 2019	-30.3112×
Jun 30, 2019	-44.3816×
Mar 31, 2019	-51.9544×
Dec 31, 2018	-49.8959×
Sep 30, 2018	-50.3928×
Jun 30, 2018	-40.3755×
Mar 31, 2018	-44.9309×
Dec 31, 2017	-43.1558×
Sep 30, 2017	0×
Jun 30, 2017	0×
Mar 31, 2017	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.